Viewing nowCombinationZadiwon Duo Tablets 5/850 mg
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jenu Pharma Co., Ltd.

MFDS item code 202201405 · Approved 2022.04.04 · Insurance code 698004700
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication can be used alongside diet and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. In particular, this medication helps effectively lower blood sugar levels by combining empagliflozin and metformin. Furthermore, it must be used with caution in adult type 2 diabetes patients with cardiovascular disease when adequate blood sugar control is not achieved. It is important to check the clinical trial information related to the risk of cardiovascular events. This medication is used to improve blood sugar control and assist in diabetes management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be given as this medicine is 1000 mg, which may be administered as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Medicine Is Contraindicated, item 2)). Older patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
This medication helps control blood sugar. However, a rare side effect called severe lactic acidosis may occur while taking this medication, which requires caution. Lactic acidosis can lead to a serious condition if lactic acid builds up in the body, so immediate consultation with a doctor is necessary if sudden muscle pain, weakness, difficulty breathing, abdominal pain, or other symptoms occur while taking this medication. When used with insulin or other diabetes medications, the risk of hypoglycemia, i.e., excessively low blood sugar, may occur, so blood sugar levels must be carefully monitored. Individuals with poor kidney function, acute kidney problems, severe infections, dehydration, heart failure, or acute myocardial infarction should not take this medication. It is necessary to temporarily stop taking this medication before and after tests using iodine contrast agents and to resume it only after confirming normal kidney function. Women who are pregnant or nursing are advised not to take this medication. Additionally, there may be an increased risk of urinary tract infections or genital infections while taking this medication, so immediate treatment should be sought if any infection symptoms appear. Furthermore, this medication can cause a reduction in fluid volume, so individuals experiencing dehydration or low blood pressure should exercise caution. Since vitamin B12 deficiency may occur, it is advisable to regularly check serum vitamin B12 levels during prolonged use. Excessive drinking or alcohol consumption may increase the risk of lactic acidosis, so it should be avoided. Elderly patients or those with impaired kidney function should adjust the dose of this medication and monitor kidney function regularly. To prevent hypoglycemia, meals should be taken regularly, and appropriate nutritional intake after exercise is necessary. Possible interactions with other medications may occur while taking this medication, so consult a doctor or pharmacist if you are taking any other medicines. Lastly, this medication is not recommended for children, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is best stored at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and ensures safe use.
White, oval-shaped, film-coated tablet with a yellow tint, biconvex on both sides
60 tablets/bottle, 30 tablets/bottle, 60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jenu Pharma Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.